In accordance with YEATS2, PIGR upregulation seems also capable of reducing survival probability in CLL patients’ samples, albeit to a lesser extent than YEATS2 and without statistical significance. The gene discussed is PIGR; the disease is B-cell chronic lymphocytic leukemia.